eMedicine Specialties > Emergency Medicine > Cardiovascular
Myopathies: Treatment & Medication
Updated: Nov 21, 2007
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
Treatment
Emergency Department Care
- Respiratory insufficiency, associated cardiomyopathy, heart block, and aspiration may result from severe myopathy. Management is supportive.
- Patients with rhabdomyolysis warrant inpatient and critical care admission to manage potentially life-threatening renal complications and hyperkalemia.
- In patients with hypokalemic periodic paralysis, IV or oral potassium replacement may be indicated.
- Swallowing usually is not impaired, and oral supplementation may blunt the acute attack.
- IV potassium should be given cautiously, if used at all.
- Attacks will resolve spontaneously within 4-24 hours, and hyperkalemia may result if potassium supplementation has been excessive.
- Spironolactone and acetazolamide are useful for prophylaxis of attacks.
- In patients with hyperkalemic periodic paralysis, attacks are often so brief that no therapy is needed.
- Some patients find that carbohydrate loading at the onset of symptoms may lessen the attack.
- Glucose and insulin may be useful in lowering serum potassium levels. Kayexalate has not been shown to be effective.
Consultations
- Neurologist
- Rheumatologist
- Infectious disease specialist
Medication
Management is supportive.
More on Myopathies |
| Overview: Myopathies |
| Differential Diagnoses & Workup: Myopathies |
Treatment & Medication: Myopathies |
| Follow-up: Myopathies |
| References |
| « Previous Page | Next Page » |
References
Ahlawat, S; Sachdev, A. Hypokalaemic paralysis. Postgrad Med J. 1999;75 (882):193-197. [Medline].
Bennett JC, Plum F. Myopathies. In: Cecil Textbook of Medicine. 20th ed. WB Saunders Co;1996:1500-03, 2158-73.
Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD. In: Harrison's Principles of Internal Medicine. 14th ed. McGraw-Hill;1998:2473-2483.
Griggs RC, Ptacek LJ. The periodic paralyses. Hosp Pract (Off Ed). Nov 15 1992;27(11):123-6, 129-30, 136-7. [Medline].
Plate AM, Boyle BA. Musculoskeletal manifestations of HIV infection. AIDS Read. Feb 2003;13(2):62, 69-70, 72, 76. [Medline].
Riggs JE, Schochet SS, Joynt RJ, Griggs RC, eds. Muscle disease. In: Clinical Neurology. Vol 4. 1997:1-37.
Stedwell RE, Allen KM, Binder LS. Hypokalemic paralyses: a review of the etiologies, pathophysiology, presentation, and therapy. Am J Emerg Med. Mar 1992;10(2):143-8. [Medline].
Stobo JD, Hellman DB. Myopathies. In: The Principles and Practice of Medicine. 23rd ed. McGraw-Hill; 1996:898-904.
Tintinelli JE, Krome RL, Ruiz E. Emergency Medicine: A Comprehensive Study Guide. 4th ed. McGraw-Hill; 1996:1036.
Wortmann RL. Lipid-lowering agents and myopathy. Curr Opin Rheumatol. Nov 2002;14(6):643-7. [Medline].
Further Reading
Keywords
disorder of skeletal muscle, myonosus, sarcoidosis, polymyositis, dermatomyositis, idiopathic myopathies, connective tissue disease, systemic lupus erythematosus, SLE, rheumatoid arthritis, RA, polyarteritis nodosa, acute alcoholic myopathy, drug-induced myopathy, thyrotoxic periodic paralysis, Conn syndrome, primary hyperaldosteronism, muscular dystrophy
Treatment & Medication: Myopathies